Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

BACKGROUND: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management. METHODS: The SCAN study was a cross-sectional multicenter French st...

Descripción completa

Detalles Bibliográficos
Autores principales: Deluche, Elise, Lachatre, Denis, Di Palma, Mario, Simon, Hélène, Tissot, Valentin, Vansteene, Damien, Meingan, Philippe, Mohebi, Alexis, Lenczner, Grégory, Pigneur, Francois, Goldwasser, Francois, Raynard, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693346/
https://www.ncbi.nlm.nih.gov/pubmed/34923226
http://dx.doi.org/10.1016/j.breast.2021.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693346/
https://www.ncbi.nlm.nih.gov/pubmed/34923226
http://dx.doi.org/10.1016/j.breast.2021.12.014

Ejemplares similares